Cell Prolif. 2025 Feb;58(2):e13768. doi: 10.1111/cpr.13768. Epub 2024 Oct 23.
J. Zhou , Y.-y. Jiang , H. Chen , Y.-c. Wu , and L. Zhang , "Tanshinone I Attenuates the Malignant Biological Properties of Ovarian Cancer by Inducing Apoptosis and Autophagy via the Inactivation of PI3K/AKT/mTOR Pathway," Cell Proliferation 53, no. 2 (2020): e12739. https://doi.org/10.1111/cpr.12739. The above article, published online on 09 December 2019, in Wiley Online Library (wileyonlinelibrary.com), and has been retracted by agreement between the journal Deputy Editor, Yunfeng Lin; and John Wiley & Sons Ltd. A third party contacted the publisher to report that duplicated images had been detected in multiple different articles by different author groups, each of which described different experimental conditions. The image duplications are listed as follows: Images in Figure 1C were duplicated in Wang et al. 2019 (https://doi.org/10.2147/OTT.S221161), which was submitted and published prior to the publication of this article in Cell Proliferation. In addition, duplicate images from Figures 1C, 1D, 2C, 3B, 3D, 4C, 4D, and 5D were detected in many other articles by different author groups that had been published subsequent to this article. The authors responded to an inquiry by the publisher regarding these concerns and shared what were labeled as original images for Figures 1-6 but did not share the original images for the cell proliferation assays that had been used in Figure 1. The editors reviewed this evidence and found that it did not properly explain the duplications across different articles. The retraction has been agreed to because the duplications of images across different articles fundamentally compromises the conclusions and results presented in the article. The authors disagree with the retraction.
周J、姜Y - y、陈H、吴Y - c和张L,“丹参酮I通过PI3K/AKT/mTOR通路失活诱导凋亡和自噬来减弱卵巢癌的恶性生物学特性”,《细胞增殖》第53卷,第2期(2020年):e12739。https://doi.org/10.1111/cpr.12739 。上述文章于2019年12月9日在线发表于威利在线图书馆(wileyonlinelibrary.com),已根据期刊副主编林云峰与约翰·威利父子有限公司的协议撤回。第三方联系出版商报告称,在不同作者团队的多篇不同文章中检测到重复图像,每篇文章描述的实验条件不同。图像重复情况如下:图1C中的图像在Wang等人2019年的文章(https://doi.org/10.2147/OTT.S221161)中重复出现,该文章在本文发表于《细胞增殖》之前已提交并发表。此外,在本文发表之后发表的许多其他不同作者团队的文章中也检测到图1C、1D、2C、3B、3D、4C、4D和5D的重复图像。作者回复了出版商关于这些问题的询问,并分享了标记为图1 - 6的原始图像,但未分享图1中细胞增殖实验所使用的原始图像。编辑审查了这些证据,发现其未能恰当解释不同文章中的重复情况。之所以同意撤回,是因为不同文章间图像的重复从根本上损害了文章中呈现的结论和结果。作者不同意撤回。